Viatris Pharmaceuticals Opens Website for School Personnel Following Administrative Notice on Administering "Spydia® Nasal Spray" for Epileptic Seizures in Schools
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Viatris Pharmaceuticals has launched a website for school personnel after an administrative notice was issued regarding the administration of "Spydia® Nasal Spray," an intranasal anti-seizure medication, during epileptic seizures in schools. This initiative responds to new guidelines allowing teachers to administer the emergency medication.